Correlation Between HLB Pharmaceutical and Korean Drug

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HLB Pharmaceutical and Korean Drug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLB Pharmaceutical and Korean Drug into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLB Pharmaceutical Co and Korean Drug Co, you can compare the effects of market volatilities on HLB Pharmaceutical and Korean Drug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLB Pharmaceutical with a short position of Korean Drug. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLB Pharmaceutical and Korean Drug.

Diversification Opportunities for HLB Pharmaceutical and Korean Drug

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between HLB and Korean is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding HLB Pharmaceutical Co and Korean Drug Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korean Drug and HLB Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLB Pharmaceutical Co are associated (or correlated) with Korean Drug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korean Drug has no effect on the direction of HLB Pharmaceutical i.e., HLB Pharmaceutical and Korean Drug go up and down completely randomly.

Pair Corralation between HLB Pharmaceutical and Korean Drug

Assuming the 90 days trading horizon HLB Pharmaceutical Co is expected to generate 2.48 times more return on investment than Korean Drug. However, HLB Pharmaceutical is 2.48 times more volatile than Korean Drug Co. It trades about 0.05 of its potential returns per unit of risk. Korean Drug Co is currently generating about -0.05 per unit of risk. If you would invest  1,255,000  in HLB Pharmaceutical Co on September 28, 2024 and sell it today you would earn a total of  965,000  from holding HLB Pharmaceutical Co or generate 76.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.79%
ValuesDaily Returns

HLB Pharmaceutical Co  vs.  Korean Drug Co

 Performance 
       Timeline  
HLB Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HLB Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Korean Drug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Korean Drug is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

HLB Pharmaceutical and Korean Drug Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HLB Pharmaceutical and Korean Drug

The main advantage of trading using opposite HLB Pharmaceutical and Korean Drug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLB Pharmaceutical position performs unexpectedly, Korean Drug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Drug will offset losses from the drop in Korean Drug's long position.
The idea behind HLB Pharmaceutical Co and Korean Drug Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.